Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Smoldering Multiple Myeloma × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Small Cell Lung Carcinoma 3 Rectal Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Fibrosis 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Sprains and Strains 1 Smoldering Multiple Myeloma 1 Sepsis 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Lenalidomide 14 Dexamethasone 12 Calcium Dobesilate 7 daratumumab 5 dexamethasone acetate 3 dexamethasone 21-phosphate 3 carfilzomib 3 auricularum 3 Melphalan 3 Curcumin 3 elotuzumab 2 PVX-410 vaccine 2 Leflunomide 2 Denosumab 2 Cyclophosphamide 2 Bortezomib 2 siltuximab 1 selinexor 1 sargramostim 1 pomalidomide 1 poly ICLC 1 piperine 1 pembrolizumab 1 ixazomib 1 isatuximab 1 ibrutinib 1 iberdomide 1 fludarabine phosphate 1 fludarabine 1 citarinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00503763 2015-04-16

PSMMSS

Meir Medical Center

Phase 2 Withdrawn

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡